| Date | Nonproprietary name (Click on each regenerative medical product name for more information [only in Japanese]) |
Detailed information on revisions of PRECAUTIONS (from MHLW) | Summary of investigation results (from PMDA) |
|---|---|---|---|
| March 28, 2024 |
Axicabtagene ciloleucel Idecabtagene vicleucel Tisagenlecleucel Lisocabtagene maraleucel |
PRECAUTIONS [30.8 KB] |
Summary of Investigation [79.5 KB] |
| January 10, 2024 |
Ciltacabtagene autoleucel | PRECAUTIONS [25.6 KB] |
Summary of Investigation [115 KB] |
| August 29, 2023 |
Axicabtagene ciloleucel Idecabtagene vicleucel Ciltacabtagene autoleucel Tisagenlecleucel Lisocabtagene maraleucel |
PRECAUTIONS [25.7 KB] |
Summary of Investigation [72.7 KB] |